bioavailability and other biological effects. Moreover, for increased bioavailability, it may be important to reduce quercetin degradation by intestinal microbiota. While there is an incredible diversity of bacteria in the large intestine, few reports have focused on quercetin-degrading human intestinal bacteria.
Grapes contain resveratrol, and its many biological effects have been reported (Rayalam et al., 2008; Bujanda et al., 2008; Gambini et al., 2015) . Further, resveratrol seems to be a potent functional food component.
In this report, we isolated and newly identified a quercetindegrading bacterium from human feces. Further, using this quercetin-degrading bacterium, we determined that resveratrol inhibits quercetin degradation.
Materials and Methods
Chemicals Quercetin and resveratrol were purchased from Funakoshi (Tokyo, Japan). Genistein was purchased from LC Laboratories (Woburn, MA, USA).
Isolation of fecal bacteria
We used a fecal tube (54 mm × 28 mm) with a small hole for stool examination (Sarstedt K.K., Tokyo, Japan). The fecal tubes were autoclave-sterilized. Fecal samples from a healthy female were sheet-collected and immediately transferred into sterilized fecal tubes. Fecal tubes were placed in an AnaeroPouch® with a CO 2 generator (Mitsubishi Gas Chemical Company Inc., Tokyo, Japan), and transported to the Food Research Institute, NARO within 24 hr at < 10℃. An approximately 0.1-g fecal sample was transferred to a sterilized glass homogenizer containing 3 mL of a pre-reduced anaerobic medium. The anaerobic medium was prepared as follows: brain heart infusion (37 g), agar (1 g), L-cysteine HCl·H 2 O (0.5 g), and Na 2 CO 3 (4 g) dissolved in 1,000 mL distilled water. Aliquots of the medium (5 mL) were then distributed to test tubes, gassed with O 2 -free CO 2 , sealed with butyl rubber stoppers, and autoclavesterilized. Feces were homogenized under gassing with O 2 -free CO 2 .
Isoflavone and arctigenin are polyphenols. It has been reported that an isoflavone-metabolizing bacterium (Yokoyama and Suzuki, 2002) was isolated from human feces by adding isoflavone to the fecal homogenate, while an arctigenin-metabolizing bacterium (Jin et al., 2002) was isolated from human feces by adding arctigenin to the anaerobic culture medium. Quercetin is a type of polyphenol; thus, to isolate quercetin-metabolizing bacteria, we added quercetin to the anaerobic medium.
To isolate quercetin-metabolizing bacteria, we first identified candidate bacteria by selecting for the de-colorization of quercetin's native yellow color in the incubation solution after anaerobic incubation of bacteria with quercetin. As the second step, quercetin degradation was confirmed by high-performance liquid chromatography (HPLC). Quercetin (20 mg) was dissolved in 1 mL dimethyl sulfoxide (DMSO). The quercetin solution (2 μL of each) was then transferred into 0.2 mL diluted fecal suspension in an anaerobic medium (as described above). The fecal suspensions with quercetin were anaerobically incubated under a CO 2 atmosphere (AnaeroPack® system, Mitsubishi Gas Chemical Company Inc.) for 24 hr at 37℃. The fecal solutions were then serially diluted 10-fold using an anaerobic dilution medium. The diluted samples were spread onto the surface of modified Gifu Anaerobic Medium (GAM) agar non-selective medium plates (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan). The plates were anaerobically incubated under a CO 2 atmosphere (AnaeroPack® system, Mitsubishi Gas Chemical Company Inc.) for 3 days at 37℃. Colonies were picked by an inoculating loop and transferred into 0.2 mL anaerobic medium and 2 μL quercetin solution (as described above). Bacterial solutions were anaerobically incubated under a CO 2 atmosphere (AnaeroPack® system, Mitsubishi Gas Chemical Company Inc.) for 2 to 3 days at 37℃. We obtained candidate quercetin-metabolizing bacteria by selecting for the decolorization of quercetin's native yellow color in the incubation solution after anaerobic incubation of bacteria with quercetin. Next, Quercetin (20 mg) was dissolved in 1 mL DMSO. Resveratrol (20 mg) and genistein (20 mg) were also dissolved in 1 mL DMSO.
In the quercetin and co-incubation experiment, 1 μL quercetin solution and 2 μL genistein, 2 μL resveratrol, or 2 μL DMSO (as control) were then transferred into 0.2 mL of strain 19 _ 20
anaerobic medium suspension and incubated anaerobically at 37℃
for 24 h.
After incubation, methanol-acetic acid (100:5, v/v) was added to the reaction mixture to a total volume of 1.0 mL. The mixture was vortexed for 120 s and centrifuged at 11,000 x g at 4℃ for 10 min. The supernatant was subjected to HPLC analysis (as described above). polymerase and EX Taq TM buffer (Takara Bio Inc., Otsu, Japan).
DNA extraction from bacteria
PCR was carried out using the Dice PCR System (Takara Bio Inc.).
The amplification program consisted of one cycle at 94℃ for 1 min, followed by 30 cycles at 94℃ for 1 min, 65℃ for 1 min, 72℃ for 1.5 min, and a final cycle at 72℃ for 2 min. The amplification products were subjected to gel electrophoresis in 0.7% agarose followed by ethidium bromide staining.
16S rRNA sequence analysis The PCR products were purified using QIAquick spin columns (Qiagen KK, Tokyo, Japan)
according to the manufacturer's instructions. Purified DNA was used for 16S rRNA sequence analysis, performed using an ABI Prism dye terminator cycle sequencing ready reaction kit (Applied Biosystems, Foster City, CA, USA), and the following sequencing primers: r1L (5'-GTATTACCGCGGCTGCTGG-3'), r2L program was used to construct a distance dendrogram, which was visualized using the MEGA6 program (Tamura et al., 2013) .
Statistics Data are expressed as the mean ± standard error (SE). All data were analyzed using Sigma Plot 13 (Systat Software, Inc., San Jose, CA, USA). The data were analyzed by the one-way analysis of variance and all pairwise multiple comparison procedures (Bonferroni t-test). Statistical significance was set at a p-value < 0.05. 
Results

Identification of bacterium
Discussion
There are few reports focusing on inhibitory polyphenols of quercetin degradation by intestinal bacteria. We isolated strain _ 20 as a quercetin-metabolizing bacterium from a healthy human. Quercetin is metabolized by the intestinal microbiota (Parkar et al., 2013) . For example, quercetin aglycones are degraded by 70% in the cecal contents of rat (Matsukawa et al., 2009 ). Quercetin was metabolized to known phenolic acid breakdown products during in vitro fermentation of the human intestinal microbiota (Parkar et al., 2013) . C. orbiscindens biotransforms quercetin and taxifolin to 3,4-dihydroxyphenylacetic acid (Schoefer et al., 2003) . There are inter-individual variations in the degradation of quercetin-3-rutinoside (Rechner et al., 2004) . Thus, quercetin bioavailability is not expected to increase in the lower gut with the simultaneous intake of genistein.
It has been reported that dietary supplementation of resveratrol suppressed 1,2-dimethylhydrazine-induced colon carcinogenesis in rats. It has also been suggested that quercetin was protective against colon carcinogenesis in colon cancer rat models (Turner et al., 2009) . Resveratrol reduced strain 19 _ 20 quercetin degradation in the present study. This raises the possibility that simultaneous intake of dietary quercetin and resveratrol may provide synergic preventive effects against colon carcinogenesis.
Dietary polyphenols affect the intestinal microbiota.
Polyphenols have been reported to affect bacterial short chain fatty acids (SCFAs) production (Parkar et al., 2013) . In turn, SCFAs are thought to affect the intestinal microbiota. Bacteroides/Prevotella counts are reported to be negatively correlated with fecal total SCFAs (Fernandes et al., 2014) . Dietary resveratrol also seems to affect the intestinal microbiota.
Lactobacilli and Bifidobacteria counts have been reported to increase after the intake of dietary resveratrol (Larrosa et al., 2009 ).
To summarize, both resveratrol and quercetin affect the intestinal microbiota. Therefore, co-administration of resveratrol and quercetin may also affect the composition of the intestinal flora.
Further studies are needed to clarify the effects of resveratrol and quercetin co-administration on the intestinal microbiota.
It has also been reported that quercetin is metabolized by Eubacterium ramulus. E. ramulus produced 3,4-dihydroxyphenylacetic acid from quercetin by anaerobic reaction (Braune et al., 2001) . C.
orbiscindens isolated from human feces was reported to biotransform quercetin and taxifolin to 3,4-dihydroxyphenylacetic acid (Schoefer et al., 2003) . Thus, both E. ramulus and C. orbiscindens degrade quercetin. Meanwhile, E. ramulus was reported to metabolize hesperetin dihydrochalcone 4′β-d-glucoside to hesperetin dihydrochalcone, whereas C. orbiscindens did not metabolize hesperetin dihydrochalcone 4′-β-d-glucoside within a period of 43 h. (Braune et al., 2005) . Thus, different levels of enzyme/polyphenol substrate specificity may exist among quercetin-metabolizing E. ramulus and C. orbiscindens.
Inter-individual variation of the intestinal microbiota has been reported (Lozupone et al., 2012) . The lower gut houses a complex bacterial community. By extension, quercetin metabolism in the lower gut is also complex. Nonetheless, diet affects the intestinal microbiota of humans (David et al., 2014) . Diets may contain many kinds of polyphenols, and dietary polyphenols could influence both the metabolism and composition of the intestinal microbiota. Further investigation of the interactions between food components and quercetin metabolism by the intestinal microbiota is warranted to improve quercetin bioavailability in humans. 
